Rutgers University’s saliva-based COVID-19 test gets FDA approval

pharmanewsdaily- April 16, 2020

New Jersey-based Rutgers University’s RUCDR Infinite Biologics and its collaborators have been granted emergency use authorization (EUA status) for their saliva-based COVID-19 test by the ... Read More